Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease atrial septal defects
Comorbidity C1619734|pulmonary arterial hypertension
Sentences 11
PubMedID- 21927863 The short- and medium-term results of transcatheter closure of atrial septal defect with severe pulmonary arterial hypertension.
PubMedID- 23302678 Objective: to analyze risk factors of pulmonary arterial hypertension (pah) in patients with atrial septal defect (asd) patients living at above 2000 m high altitude area.
PubMedID- 24157161 The objective of this study was to explore the fasting plasma ghrelin level and the relationships between ghrelin and pulmonary arterial pressure (pap) in atrial septal defect (asd) patients with pulmonary arterial hypertension (pah).
PubMedID- 25269902 Inaccuracy of doppler echocardiographic estimates of pulmonary artery pressures in adult atrial septal defect patients with pulmonary arterial hypertension.
PubMedID- 23499807 We investigated plasma nt-probnp levels and the relationships between nt-probnp and several hemodynamic parameters in atrial septal defect (asd) patients with or without pulmonary arterial hypertension (pah).
PubMedID- 24198921 Device closure of a large atrial septal defect in a patient with severe pulmonary arterial hypertension after 1 year use of an oral endothelin receptor antagonist.
PubMedID- 22977443 Bronchial compression in an infant with isolated secundum atrial septal defect associated with severe pulmonary arterial hypertension.
PubMedID- 25742945 Background: therapeutic strategies for pulmonary arterial hypertension (pah) associated with atrial septal defect (asd) remain a matter of debate.
PubMedID- 22073329 atrial septal defect (asd) with severe pulmonary arterial hypertension (pah) is thought to preclude shunt closure.
PubMedID- 23595779 Subsequent shunt closure after targeted medical therapy can be an effective strategy for secundum atrial septal defect with severe pulmonary arterial hypertension: two case reports : strategy for asd with severe pah.
PubMedID- 22449225 The expression of cd44 was examined in lung plexiform lesions obtained from patients with ipah (ipah group, n= 7) and pulmonary arterial hypertension associated with atrial septal defect (asd-pah group, n= 4).

Page: 1